A Review of Fatty Acid Biosynthesis Enzyme Inhibitors as Promising Antimicrobial Drugs
Open Access
- 10 March 2023
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (3) , 425
Abstract
Resistance to antimicrobial drugs is currently a serious threat to human health. Consequently, we are facing an urgent need for new antimicrobial drugs acting with original modes of action. The ubiquitous and widely conserved microbial fatty acid biosynthesis pathway, called FAS-II system, represents a potential target to tackle antimicrobial resistance. This pathway has been extensively studied, and eleven proteins have been described. FabI (or InhA, its homologue in mycobacteria) was considered as a prime target by many teams and is currently the only enzyme with commercial inhibitor drugs: triclosan and isoniazid. Furthermore, afabicin and CG400549, two promising compounds which also target FabI, are in clinical assays to treat Staphylococcus aureus. However, most of the other enzymes are still underexploited targets. This review, after presenting the FAS-II system and its enzymes in Escherichia coli, highlights the reported inhibitors of the system. Their biological activities, main interactions formed with their targets and structure–activity relationships are presented as far as possible.Keywords
Funding Information
- Aid (2020-65-0014, ALRC2.0-000168)
- Hauts-de-France Region (2020-65-0014, ALRC2.0-000168)
This publication has 177 references indexed in Scilit:
- Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-acyl-ACP Reductase from Pseudomonas aeruginosaACS Chemical Biology, 2013
- Structure of the Yersinia pestis FabV Enoyl-ACP Reductase and Its Interaction with Two 2-Pyridone InhibitorsStructure, 2012
- Crystal structures of bacterial FabH suggest a molecular basis for the substrate specificity of the enzymeFEBS Letters, 2009
- Three flavonoids targeting the β‐hydroxyacyl‐acyl carrier protein dehydratase from Helicobacter pylori: Crystal structure characterization with enzymatic inhibition assayProtein Science, 2008
- Design and Synthesis of Aryl Ether Inhibitors of the Bacillus Anthracis Enoyl‐ACP ReductaseChemMedChem, 2008
- Crystal structure of enoyl–acyl carrier protein reductase (FabK) from Streptococcus pneumoniae reveals the binding mode of an inhibitorProtein Science, 2008
- Structure ofMycobacterium tuberculosismtFabD, a malonyl-CoA:acyl carrier protein transacylase (MCAT)Acta Crystallographica Section F Structural Biology and Crystallization Communications, 2007
- Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic propertiesProceedings of the National Academy of Sciences, 2007
- X-Ray Crystal Structure of Mycobacterium tuberculosis β-Ketoacyl Acyl Carrier Protein Synthase II (mtKasB)Journal of Molecular Biology, 2007
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996